Literature DB >> 25355974

Changes in immunization program managers' perceptions of programs' functional capabilities during and after vaccine shortages and pH1N1.

Leah F Moriarty1, Saad B Omer2, Katherine Seib3, Allison Chamberlain4, Katelyn Wells5, Ellen Whitney4, Ruth Berkelman4, Robert A Bednarczyk1.   

Abstract

OBJECTIVES: We surveyed U.S. immunization program managers (IPMs) as part of a project to improve public health preparedness against future emergencies by leveraging the immunization system. We examined immunization program policy and Immunization Information System (IIS) functionality changes as a result of the Haemophilus influenzae type B (Hib) vaccine shortage and pandemic influenza A(H1N1) (pH1N1). Evaluating changes in immunization program functionalities and policies following emergency response situations will assist in planning for future vaccine-related emergencies.
METHODS: We administered three consecutive surveys to IPMs from 64 state, city, and territorial jurisdictions in 2009, 2010, and 2012. We compared IPMs' responses across either two or three years (e.g., changes in response or consistent responses across years) using McNemar's test.
RESULTS: Immunization programs maintained increases in functionality related to communication systems with health-care providers during this period. Immunization programs often did not maintain changes to IIS functionalities made from 2009 to 2010 (e.g., identifying high-risk and priority populations, tracking adverse events, and mapping disease risk) in the post-pandemic period (2010-2012). About half of IPMs reporting additional IIS functionality in identifying high-risk populations from 2009 to 2010 reported no longer having this function in 2012. There was an 18% decline in respondents reporting geographic information systems risk-mapping capability in IIS from 2010 to 2012.
CONCLUSIONS: Because of the Hib vaccine shortage and pH1N1, immunization program needs and efforts changed to address evolving situations. The lack of sustained increases in resources or system functions after the pandemic highlights the need for comprehensive, sustainable public health emergency preparedness systems and related resources.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25355974      PMCID: PMC4187306          DOI: 10.1177/00333549141296S407

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  10 in total

1.  Lessons learned from the 2007 to 2009 Haemophilus influenzae type B vaccine shortage: implications for future vaccine shortages and public health preparedness.

Authors:  Allison T Chamberlain; Katelyn Wells; Katherine Seib; Amanda Kudis; Claire Hannan; Walter A Orenstein; Ellen A S Whitney; Alan R Hinman; James W Buehler; Saad B Omer; Ruth L Berkelman
Journal:  J Public Health Manag Pract       Date:  2012 May-Jun

2.  Perspectives of immunization program managers on 2009-10 H1N1 vaccination in the United States: a national survey.

Authors:  Allison T Chamberlain; Katherine Seib; Katelyn Wells; Claire Hannan; Walter A Orenstein; Ellen A S Whitney; Alan R Hinman; Ruth L Berkelman; Saad B Omer
Journal:  Biosecur Bioterror       Date:  2012-02-23

3.  Mass vaccination for the 2009 H1N1 pandemic: approaches, challenges, and recommendations.

Authors:  Kunal J Rambhia; Matthew Watson; Tara Kirk Sell; Richard Waldhorn; Eric Toner
Journal:  Biosecur Bioterror       Date:  2010-11-02

4.  Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010.

Authors:  W Katherine Yih; Grace M Lee; Tracy A Lieu; Robert Ball; Martin Kulldorff; Melisa Rett; Peter M Wahl; Cheryl N McMahill-Walraven; Richard Platt; Daniel A Salmon
Journal:  Am J Epidemiol       Date:  2012-05-11       Impact factor: 4.897

5.  State, territorial, and local health departments' reporting of partnership strength before and after the H1N1 response.

Authors:  Karen E Kun; John Zimmerman; Dale A Rose; Stephanie Rubel
Journal:  Prehosp Disaster Med       Date:  2013-11-07       Impact factor: 2.040

6.  Challenges and changes: immunization program managers share perspectives in a 2012 national survey about the US immunization system since the H1N1 pandemic response.

Authors:  Katherine Seib; Allison Chamberlain; Katelyn Wells; Eileen Curran; Ellen As Whitney; Walter A Orenstein; Alan R Hinman; Saad B Omer
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

7.  Adverse pregnancy outcomes (APOs) and periodontal disease: pathogenic mechanisms.

Authors:  Phoebus N Madianos; Yiorgos A Bobetsis; Steven Offenbacher
Journal:  J Clin Periodontol       Date:  2013-04       Impact factor: 8.728

Review 8.  Immune responses and protection in children in developing countries induced by oral vaccines.

Authors:  Firdausi Qadri; Taufiqur Rahman Bhuiyan; David A Sack; Ann-Mari Svennerholm
Journal:  Vaccine       Date:  2012-11-12       Impact factor: 3.641

9.  Lessons about the state and local public health system response to the 2009 H1N1 pandemic: a workshop summary.

Authors:  Michael A Stoto; Christopher Nelson; Melissa A Higdon; John Kraemer; Lisle Hites; Christa-Marie Singleton
Journal:  J Public Health Manag Pract       Date:  2013 Sep-Oct

10.  Learning about after action reporting from the 2009 H1N1 pandemic: a workshop summary.

Authors:  Michael A Stoto; Christopher Nelson; Melissa A Higdon; John Kraemer; Christa-Marie Singleton
Journal:  J Public Health Manag Pract       Date:  2013 Sep-Oct
  10 in total
  2 in total

1.  Preparedness and emergency response research centers: early returns on investment in evidence-based public health systems research.

Authors:  Shoukat H Qari; David M Abramson; Jane A Kushma; Paul K Halverson
Journal:  Public Health Rep       Date:  2014       Impact factor: 2.792

2.  ReadyVax: A new mobile vaccine information app.

Authors:  Robert A Bednarczyk; Paula M Frew; Daniel A Salmon; Ellen Whitney; Saad B Omer
Journal:  Hum Vaccin Immunother       Date:  2017-01-06       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.